Pharmaceutical Value Proposition

Produces an evidence-based value story/narrative for a drug asset tailored to payer and HTA audiences. Should translate clinical trial data and real-world evidence into economic and humanistic value claims. Include clinical differentiation, unmet need framing, budget impact framing, and key messages by stakeholder type (payer, physician, patient).